Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AKAMAI TECHNOLOGIES INCAKAM · Entity 3352 | Director | May 15, 2019 | May 17, 2019 |
| Moderna, Inc.MRNA · Entity 2025 | Director | April 30, 2025 | May 01, 2025 |
| Okta, Inc.OKTA · Entity 3154 | Director | June 18, 2026 | June 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AKAMAI TECHNOLOGIES INC
Report date May 15, 2019 · Filed May 17, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $.01 per shareSEC Table I · non-derivative | Direct | 71,750 |
Reported balance
After 2019-05-15 transaction · row 1
1 source rowRow 1 · 2019-05-15 · Exercise / conversion · Acquired 12,072 · Balance 71,750 F1: Represents total of all deferred unit distributions ("DSUs") on May 15, 2019 reflected on Table II below. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2019-05-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-05-15 · Exercise / conversion · Disposed 4,580 · Balance 0 F2: DSUs represent the right to receive one share of Akamai common stock upon vesting. Distribution of these vested DSUs was deferred until Mr. Sagan's departure from the Board of Directors on May 15, 2019. F3: Not applicable. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2019-05-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-05-15 · Exercise / conversion · Disposed 4,532 · Balance 0 F2: DSUs represent the right to receive one share of Akamai common stock upon vesting. Distribution of these vested DSUs was deferred until Mr. Sagan's departure from the Board of Directors on May 15, 2019. F3: Not applicable. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2019-05-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-05-15 · Exercise / conversion · Disposed 2,960 · Balance 0 F4: Each DSU represents the right to receive 1 share of common stock upon vesting. F3: Not applicable. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents total of all deferred unit distributions ("DSUs") on May 15, 2019 reflected on Table II below.
F2: DSUs represent the right to receive one share of Akamai common stock upon vesting. Distribution of these vested DSUs was deferred until Mr. Sagan's departure from the Board of Directors on May 15, 2019.
F3: Not applicable.
F4: Each DSU represents the right to receive 1 share of common stock upon vesting.
Moderna, Inc.
Report date April 30, 2025 · Filed May 01, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.54 · Expires 2035-04-30 | Direct | 25,512 |
Reported balance
After 2025-04-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-04-30 · Grant · Acquired 25,512 · Balance 25,512 F1: This option will become fully vested and exercisable on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: This option will become fully vested and exercisable on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.
Okta, Inc.
Report date June 18, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,080 |
Reported balance
After 2026-06-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-18 · Grant · Acquired 2,080 · Balance 2,080 F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Class A Common Stock. F2: The RSUs vest in full on the earlier of June 18, 2027 or the date immediately prior to the Issuer's next regular annual stockholder meeting, subject to the Reporting Person's continued service to the Issuer through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Class A Common Stock.
F2: The RSUs vest in full on the earlier of June 18, 2027 or the date immediately prior to the Issuer's next regular annual stockholder meeting, subject to the Reporting Person's continued service to the Issuer through such vesting date.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Catalyst Partners Acquisition Corp.
Report date February 07, 2023 · Filed February 10, 2023
Section 16 reporting ended · disclosed 2023-02-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Ordinary SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-02-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-02-07 · Other · Disposed 37,000 · Balance 0 F1: On January 31, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the "Articles") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by the Reporting Person were surrendered for no compensation on February 7, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: On January 31, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the "Articles") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by the Reporting Person were surrendered for no compensation on February 7, 2023.
EMC CORP
Report date September 06, 2016 · Filed September 08, 2016
Section 16 reporting ended · disclosed 2016-09-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2016-09-07 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2016-09-06 · Exercise / conversion · Acquired 10,000 · Balance 85,800 F1: In connection with the merger (the "Merger") of Universal Acquisition Co. with and into EMC Corporation on September 7, 2016, these shares were acquired pursuant to the automatic net exercise of stock options occurring immediately prior to 11:59 p.m., New York City time on September 6, 2016 (the "Vesting Effective Time"). Row 2 · 2016-09-06 · Tax withholding · Disposed 6,010 · Balance 79,790 F2: Consists of shares withheld by EMC to satisfy the applicable exercise price upon exercise of options and associated tax withholding obligations related to the automatic net exercise of options immediately prior to the Vesting Effective Time described in footnote 1 above. Row 3 · 2016-09-06 · Exercise / conversion · Acquired 10,000 · Balance 89,790 F1: In connection with the merger (the "Merger") of Universal Acquisition Co. with and into EMC Corporation on September 7, 2016, these shares were acquired pursuant to the automatic net exercise of stock options occurring immediately prior to 11:59 p.m., New York City time on September 6, 2016 (the "Vesting Effective Time"). Row 4 · 2016-09-06 · Tax withholding · Disposed 4,443 · Balance 85,347 F2: Consists of shares withheld by EMC to satisfy the applicable exercise price upon exercise of options and associated tax withholding obligations related to the automatic net exercise of options immediately prior to the Vesting Effective Time described in footnote 1 above. Row 5 · 2016-09-06 · Exercise / conversion · Acquired 10,000 · Balance 95,347 F1: In connection with the merger (the "Merger") of Universal Acquisition Co. with and into EMC Corporation on September 7, 2016, these shares were acquired pursuant to the automatic net exercise of stock options occurring immediately prior to 11:59 p.m., New York City time on September 6, 2016 (the "Vesting Effective Time"). Row 6 · 2016-09-06 · Tax withholding · Disposed 6,824 · Balance 88,523 F2: Consists of shares withheld by EMC to satisfy the applicable exercise price upon exercise of options and associated tax withholding obligations related to the automatic net exercise of options immediately prior to the Vesting Effective Time described in footnote 1 above. Row 7 · 2016-09-07 · Disposition to issuer · Disposed 88,523 · Balance 0 F3: In connection with the Merger, at the effective time of the Merger, each outstanding share of EMC Corporation common stock beneficially owned by the reporting person was automatically canceled and converted into the right to receive (i) $24.05 in cash and (ii) 0.11146 of a share of Class V Common Stock of Dell Technologies Inc. (f/k/a Denali Holding Inc.). |
| Stock Option Right To BuySEC Table II · derivative / convertible security · Conversion / exercise price $17.29 · Expires 2018-05-21 | Direct | 0 |
Reported balance
After 2016-09-06 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2016-09-06 · Exercise / conversion · Disposed 10,000 · Balance 0 F4: In connection with the merger (the "Merger") of Universal Acquisition Co. with and into EMC Corporation on September 7, 2016, these stock options were automatically net exercised immediately prior to 11:59 p.m., New York City time on September 6, 2016 (the "Vesting Effective Time"). |
| Stock Option Right To BuySEC Table II · derivative / convertible security · Conversion / exercise price $12.78 · Expires 2019-05-06 | Direct | 0 |
Reported balance
After 2016-09-06 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2016-09-06 · Exercise / conversion · Disposed 10,000 · Balance 0 F4: In connection with the merger (the "Merger") of Universal Acquisition Co. with and into EMC Corporation on September 7, 2016, these stock options were automatically net exercised immediately prior to 11:59 p.m., New York City time on September 6, 2016 (the "Vesting Effective Time"). |
| Stock Option Right To BuySEC Table II · derivative / convertible security · Conversion / exercise price $19.63 · Expires 2020-04-29 | Direct | 0 |
Reported balance
After 2016-09-06 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2016-09-06 · Exercise / conversion · Disposed 10,000 · Balance 0 F4: In connection with the merger (the "Merger") of Universal Acquisition Co. with and into EMC Corporation on September 7, 2016, these stock options were automatically net exercised immediately prior to 11:59 p.m., New York City time on September 6, 2016 (the "Vesting Effective Time"). |
Filing footnotes · ownership attribution and instrument terms
F1: In connection with the merger (the "Merger") of Universal Acquisition Co. with and into EMC Corporation on September 7, 2016, these shares were acquired pursuant to the automatic net exercise of stock options occurring immediately prior to 11:59 p.m., New York City time on September 6, 2016 (the "Vesting Effective Time").
F2: Consists of shares withheld by EMC to satisfy the applicable exercise price upon exercise of options and associated tax withholding obligations related to the automatic net exercise of options immediately prior to the Vesting Effective Time described in footnote 1 above.
F3: In connection with the Merger, at the effective time of the Merger, each outstanding share of EMC Corporation common stock beneficially owned by the reporting person was automatically canceled and converted into the right to receive (i) $24.05 in cash and (ii) 0.11146 of a share of Class V Common Stock of Dell Technologies Inc. (f/k/a Denali Holding Inc.).
F4: In connection with the merger (the "Merger") of Universal Acquisition Co. with and into EMC Corporation on September 7, 2016, these stock options were automatically net exercised immediately prior to 11:59 p.m., New York City time on September 6, 2016 (the "Vesting Effective Time").
VMWARE LLC
Report date November 22, 2023 · Filed November 22, 2023
Section 16 reporting ended · disclosed 2023-11-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2023-11-22 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-11-22 · Disposition to issuer · Disposed 22,911 · Balance 1,482 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of May 26, 2022 (the "Merger Agreement"), by and among VMware, Inc. (the "Issuer"), Broadcom Inc. ("Parent"), Verona Holdco, Inc., a direct wholly owned subsidiary of the Issuer ("Holdco"), Verona Merger Sub, Inc., a direct wholly owned subsidiary of Holdco, Barcelona Merger Sub 2, Inc., a direct wholly owned subsidiary of Parent, and Barcelona Merger Sub 3, LLC, a direct wholly owned subsidiary of Parent. F2: (Continued from Footnote 1) Under the terms of the Merger Agreement, each share of the Issuer's Class A common stock, par value $0.01 per share (the "Common Stock"), issued and outstanding was indirectly converted into the right to receive, at the election of the holder of such share of Common Stock, and subject to proration in accordance with the Merger Agreement: (i) $142.50 per share in cash, without interest (the "Cash Consideration"), or (ii) 0.25200 shares of common stock, par value $0.001 per share of Parent (the "Stock Consideration"). Row 2 · 2023-11-22 · Disposition to issuer · Disposed 1,482 · Balance 0 F3: Represents shares underlying restricted stock units of the Issuer, which were vested and cancelled in exchange for the right to receive a payment equal to 50% of the Cash Consideration and 50% of the Stock Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of May 26, 2022 (the "Merger Agreement"), by and among VMware, Inc. (the "Issuer"), Broadcom Inc. ("Parent"), Verona Holdco, Inc., a direct wholly owned subsidiary of the Issuer ("Holdco"), Verona Merger Sub, Inc., a direct wholly owned subsidiary of Holdco, Barcelona Merger Sub 2, Inc., a direct wholly owned subsidiary of Parent, and Barcelona Merger Sub 3, LLC, a direct wholly owned subsidiary of Parent.
F2: (Continued from Footnote 1) Under the terms of the Merger Agreement, each share of the Issuer's Class A common stock, par value $0.01 per share (the "Common Stock"), issued and outstanding was indirectly converted into the right to receive, at the election of the holder of such share of Common Stock, and subject to proration in accordance with the Merger Agreement: (i) $142.50 per share in cash, without interest (the "Cash Consideration"), or (ii) 0.25200 shares of common stock, par value $0.001 per share of Parent (the "Stock Consideration").
F3: Represents shares underlying restricted stock units of the Issuer, which were vested and cancelled in exchange for the right to receive a payment equal to 50% of the Cash Consideration and 50% of the Stock Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2026 Filed Jun 22, 2026 22:49 UTC | Okta, Inc. OKTA · Entity 3154 | GrantRestricted Stock Units · Derivative | 2,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-044758 · wk-form4_1782168555.xml · derivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,080 Underlying: Class A Common Stock · 2,080 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: The RSUs vest in full on the earlier of June 18, 2027 or the date immediately prior to the Issuer's next regular annual stockholder meeting, subject to the Reporting Person's continued service to the Issuer through such vesting date. F2 · derivative.expiration_date: The RSUs vest in full on the earlier of June 18, 2027 or the date immediately prior to the Issuer's next regular annual stockholder meeting, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| December 19, 2025 Filed Dec 22, 2025 22:36 UTC | Okta, Inc. OKTA · Entity 3154 | GrantRestricted Stock Units · Derivative | 5,876 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-058604 · wk-form4_1766442978.xml · derivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,876 Underlying: Class A Common Stock · 5,876 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: 33-1/3% of the shares underlying the RSU shall vest on December 19, 2026, and the remaining shares underlying the RSU shall vest in 2 equal annual installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such date. F2 · derivative.expiration_date: 33-1/3% of the shares underlying the RSU shall vest on December 19, 2026, and the remaining shares underlying the RSU shall vest in 2 equal annual installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such date. Read SEC document |
| April 30, 2025 Filed May 1, 2025 20:35 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantStock Option (Right to Buy) · Derivative | 25,512 | $0.00 Strike: $28.54 | $0.00 |
DisclosureSEC source: 0001127602-25-012945 · form4.xml · derivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,512 Underlying: Common Stock · 25,512 shares Expires 2035-04-30 F1 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:24 UTC | Moderna, Inc. MRNA · Entity 2025 | PurchaseCommon Stock | 31,620 | $31.76 | $1,004,251.20 |
DisclosureSEC source: 0001127602-25-007904 · form4.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By: The Paul Sagan Revocable Trust Disclosed balance after: 312,027 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.46 to $31.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F2 · balance_after: This balance reflects the transfer of 90,000 shares of the Issuer's common stock from The Paul Sagan Revocable Trust to The Chatham Trust on November 21, 2024. Read SEC document |
| May 06, 2024 Filed May 7, 2024 20:59 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantStock Option (Right to Buy) · Derivative | 7,557 | $0.00 Strike: $122.13 | $0.00 |
DisclosureSEC source: 0001127602-24-014470 · form4.xml · derivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,557 Underlying: Common Stock · 7,557 shares Expires 2034-05-06 F1 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document |
| November 22, 2023 Filed Nov 22, 2023 19:35 UTC | VMWARE LLC VMW · Entity 11690 | Disposition to issuerClass A Common Stock | 1,482 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-020483 · doc4.xml · nonDerivative · entry 2 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F3 · shares: Represents shares underlying restricted stock units of the Issuer, which were vested and cancelled in exchange for the right to receive a payment equal to 50% of the Cash Consideration and 50% of the Stock Consideration. F3 · price: Represents shares underlying restricted stock units of the Issuer, which were vested and cancelled in exchange for the right to receive a payment equal to 50% of the Cash Consideration and 50% of the Stock Consideration. Read SEC document |
| November 22, 2023 Filed Nov 22, 2023 19:35 UTC | VMWARE LLC VMW · Entity 11690 | Disposition to issuerClass A Common Stock | 22,911 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-020483 · doc4.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,482 F1 · shares: Disposed of pursuant to the Agreement and Plan of Merger, dated as of May 26, 2022 (the "Merger Agreement"), by and among VMware, Inc. (the "Issuer"), Broadcom Inc. ("Parent"), Verona Holdco, Inc., a direct wholly owned subsidiary of the Issuer ("Holdco"), Verona Merger Sub, Inc., a direct wholly owned subsidiary of Holdco, Barcelona Merger Sub 2, Inc., a direct wholly owned subsidiary of Parent, and Barcelona Merger Sub 3, LLC, a direct wholly owned subsidiary of Parent. F2 · shares: (Continued from Footnote 1) Under the terms of the Merger Agreement, each share of the Issuer's Class A common stock, par value $0.01 per share (the "Common Stock"), issued and outstanding was indirectly converted into the right to receive, at the election of the holder of such share of Common Stock, and subject to proration in accordance with the Merger Agreement: (i) $142.50 per share in cash, without interest (the "Cash Consideration"), or (ii) 0.25200 shares of common stock, par value $0.001 per share of Parent (the "Stock Consideration"). F1 · price: Disposed of pursuant to the Agreement and Plan of Merger, dated as of May 26, 2022 (the "Merger Agreement"), by and among VMware, Inc. (the "Issuer"), Broadcom Inc. ("Parent"), Verona Holdco, Inc., a direct wholly owned subsidiary of the Issuer ("Holdco"), Verona Merger Sub, Inc., a direct wholly owned subsidiary of Holdco, Barcelona Merger Sub 2, Inc., a direct wholly owned subsidiary of Parent, and Barcelona Merger Sub 3, LLC, a direct wholly owned subsidiary of Parent. F2 · price: (Continued from Footnote 1) Under the terms of the Merger Agreement, each share of the Issuer's Class A common stock, par value $0.01 per share (the "Common Stock"), issued and outstanding was indirectly converted into the right to receive, at the election of the holder of such share of Common Stock, and subject to proration in accordance with the Merger Agreement: (i) $142.50 per share in cash, without interest (the "Cash Consideration"), or (ii) 0.25200 shares of common stock, par value $0.001 per share of Parent (the "Stock Consideration"). Read SEC document |
| July 13, 2023 Filed Jul 14, 2023 23:23 UTC | VMWARE LLC VMW · Entity 11690 | GrantClass A Common Stock | 1,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-042318 · doc4.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,393 Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:15 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantStock Option (Right to Buy) · Derivative | 6,134 | $0.00 Strike: $130.14 | $0.00 |
DisclosureSEC source: 0001127602-23-014682 · form4.xml · derivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,134 Underlying: Common Stock · 6,134 shares Expires 2033-05-03 F1 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of May 3, 2024, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document |
| February 07, 2023 Filed Feb 10, 2023 02:10 UTC | Catalyst Partners Acquisition Corp. CPAR · Entity 117079 | OtherClass B Ordinary Shares · Derivative | 37,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-017802 · tm236060-9_4seq1.xml · derivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Ordinary Shares · 37,000 shares Expires not disclosed F1 · derivative.exercise_price: On January 31, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the "Articles") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by the Reporting Person were surrendered for no compensation on February 7, 2023. F1 · derivative.exercise_date: On January 31, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the "Articles") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by the Reporting Person were surrendered for no compensation on February 7, 2023. F1 · derivative.expiration_date: On January 31, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the "Articles") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by the Reporting Person were surrendered for no compensation on February 7, 2023. Read SEC document |
| July 12, 2022 Filed Jul 14, 2022 23:21 UTC | VMWARE LLC VMW · Entity 11690 | GrantClass A Common Stock | 2,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-042178 · doc4.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,417 F1 · balance_after: Reflects equitable adjustment to the number of unvested RSUs as of November 1, 2021 in connection with VMware's special cash dividend. Pursuant to the adjustment, the number of unvested RSUs was multiplied by a conversion factor of 1.2191. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:42 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantStock Option (Right to Buy) · Derivative | 5,415 | $0.00 Strike: $142.52 | $0.00 |
DisclosureSEC source: 0001127602-22-012858 · form4.xml · derivative · entry 6 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,415 Underlying: Common Stock · 5,415 shares Expires not disclosed F4 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. F4 · derivative.expiration_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:42 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 703 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012858 · form4.xml · derivative · entry 5 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 703 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. F3 · derivative.expiration_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:42 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 703 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012858 · form4.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:03 UTC | Moderna, Inc. MRNA · Entity 2025 | SaleCommon Stock | 2,250 | $314.90 | $708,525.00 |
DisclosureSEC source: 0001127602-21-027120 · form4.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Erwin Park LLC Disclosed balance after: 14,951 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2021. F2 · ownership.direct: Erwin Park LLC is an estate planning vehicle for the Reporting Person's family. The Chatham Trust is an irrevocable family trust for which the Reporting Person serves as a trustee. The Paul Sagan Revocable Trust is a revocable trust for which the Reporting Person serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 12, 2021 Filed Aug 13, 2021 20:08 UTC | Moderna, Inc. MRNA · Entity 2025 | GiftCommon Stock | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-023650 · form4.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: The Paul Sagan Revocable Trust Disclosed balance after: 370,407 F1 · price: The reported disposition represents a bona fide charitable gift made by the reporting person. Read SEC document |
| July 23, 2021 Filed Jul 26, 2021 23:40 UTC | VMWARE LLC VMW · Entity 11690 | GrantClass A Common Stock | 1,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048245 · doc4.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,875 Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:13 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantRestricted Stock Units · Derivative | 703 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014776 · form4.xml · derivative · entry 2 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703 Underlying: Common Stock · 703 shares Expires not disclosed F2 · derivative.exercise_date: The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2022, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. F2 · derivative.expiration_date: The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2022, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:13 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantStock Option (Right to Buy) · Derivative | 4,081 | $0.00 Strike: $178.68 | $0.00 |
DisclosureSEC source: 0001127602-21-014776 · form4.xml · derivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,081 Underlying: Common Stock · 4,081 shares Expires 2031-04-28 F1 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of April 28, 2022, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 23:47 UTC | VMWARE LLC VMW · Entity 11690 | GrantClass A Common Stock | 1,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043003 · doc4.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,255 Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 21:30 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantStock Option (Right to Buy) · Derivative | 18,270 | $0.00 Strike: $46.37 | $0.00 |
DisclosureSEC source: 0001127602-20-014876 · form4.xml · derivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,270 Underlying: Common Stock · 18,270 shares Expires 2030-04-29 F1 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of April 29, 2021, or the next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 21:09 UTC | Moderna, Inc. MRNA · Entity 2025 | PurchaseCommon Stock | 52,631 | $19.00 | $999,989.00 |
DisclosureSEC source: 0001127602-20-006018 · form4.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: The Paul Sagan Revocable Trust Disclosed balance after: 420,407 F1 · ownership.direct: Erwin Park LLC is an estate planning vehicle for the Reporting Person's family. The Chatham Trust is an irrevocable family trust for which the Reporting Person serves as a trustee. The Paul Sagan Revocable Trust is a revocable trust for which the Reporting Person serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| June 27, 2019 Filed Jun 28, 2019 20:29 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantStock Option (Right to Buy) · Derivative | 54,660 | $0.00 Strike: $14.34 | $0.00 |
DisclosureSEC source: 0001127602-19-023027 · form4.xml · derivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,660 Underlying: Common Stock · 54,660 shares Expires 2029-06-27 F1 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of June 27, 2020, or the next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 23:20 UTC | VMWARE LLC VMW · Entity 11690 | GrantClass A Common Stock | 1,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-039369 · doc4.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,415 F1 · balance_after: Reflects equitable adjustment to the number of unvested RSUs as of December 28, 2018 in connection with VMware's special cash dividend. Pursuant to the adjustment, the number of unvested RSUs was multiplied by a conversion factor of 1.2038. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:18 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | Exercise / conversionDeferred Stock Units · Derivative | 2,960 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001086222-19-000155 · wf-form4_155812430953472.xml · derivative · entry 4 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,960 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Each DSU represents the right to receive 1 share of common stock upon vesting. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:18 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | Exercise / conversionDeferred Stock Units · Derivative | 4,532 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001086222-19-000155 · wf-form4_155812430953472.xml · derivative · entry 3 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,532 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: DSUs represent the right to receive one share of Akamai common stock upon vesting. Distribution of these vested DSUs was deferred until Mr. Sagan's departure from the Board of Directors on May 15, 2019. F2 · derivative.exercise_date: DSUs represent the right to receive one share of Akamai common stock upon vesting. Distribution of these vested DSUs was deferred until Mr. Sagan's departure from the Board of Directors on May 15, 2019. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:18 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | Exercise / conversionDeferred Stock Units · Derivative | 4,580 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001086222-19-000155 · wf-form4_155812430953472.xml · derivative · entry 2 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,580 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: DSUs represent the right to receive one share of Akamai common stock upon vesting. Distribution of these vested DSUs was deferred until Mr. Sagan's departure from the Board of Directors on May 15, 2019. F2 · derivative.exercise_date: DSUs represent the right to receive one share of Akamai common stock upon vesting. Distribution of these vested DSUs was deferred until Mr. Sagan's departure from the Board of Directors on May 15, 2019. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:18 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | Exercise / conversionCommon Stock, par value $.01 per share | 12,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001086222-19-000155 · wf-form4_155812430953472.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents total of all deferred unit distributions ("DSUs") on May 15, 2019 reflected on Table II below. Read SEC document |
| December 11, 2018 Filed Dec 13, 2018 21:25 UTC | Moderna, Inc. MRNA · Entity 2025 | ConversionSeries B Preferred Stock · Derivative | 367,776 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-030866 · doc4.xml · derivative · entry 4 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: The Paul Sagan Revocable Trust Disclosed balance after: 0 Underlying: Common Stock · 367,776 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series B Preferred Stock (the "Preferred Stock") converted into Common Stock based on an applicable conversion ratio of 0.45457 upon the closing of the Issuer's initial public offering on December 11, 2018. The Preferred Stock had no expiration date. F1 · price: The Series B Preferred Stock (the "Preferred Stock") converted into Common Stock based on an applicable conversion ratio of 0.45457 upon the closing of the Issuer's initial public offering on December 11, 2018. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: The Series B Preferred Stock (the "Preferred Stock") converted into Common Stock based on an applicable conversion ratio of 0.45457 upon the closing of the Issuer's initial public offering on December 11, 2018. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: The Series B Preferred Stock (the "Preferred Stock") converted into Common Stock based on an applicable conversion ratio of 0.45457 upon the closing of the Issuer's initial public offering on December 11, 2018. The Preferred Stock had no expiration date. F2 · derivative.underlying_shares: Erwin Park LLC is an estate planning vehicle for the Reporting Person's family. The Chatham Trust is an irrevocable family trust for which the Reporting Person serves as a trustee. The Paul Sagan Revocable Trust is a revocable trust for which the Reporting Person serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 11, 2018 Filed Dec 13, 2018 21:25 UTC | Moderna, Inc. MRNA · Entity 2025 | ConversionCommon Stock | 367,776 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-030866 · doc4.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: The Paul Sagan Revocable Trust Disclosed balance after: 367,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series B Preferred Stock (the "Preferred Stock") converted into Common Stock based on an applicable conversion ratio of 0.45457 upon the closing of the Issuer's initial public offering on December 11, 2018. The Preferred Stock had no expiration date. F2 · balance_after: Erwin Park LLC is an estate planning vehicle for the Reporting Person's family. The Chatham Trust is an irrevocable family trust for which the Reporting Person serves as a trustee. The Paul Sagan Revocable Trust is a revocable trust for which the Reporting Person serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 12, 2018 Filed Jan 4, 2019 22:13 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | GiftCommon Stock, par value $.01 per share | 28,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001086222-19-000005 · wf-form5_154664001794409.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See note Disclosed balance after: 364,729 F1 · ownership.direct: Held by the Paul Sagan Revocable Trust. Mr. Sagan disclaims beneficial ownership of shares held by the Paul Sagan Revocable Trust except to the extent of his pecuniary interest therein. F1 · ownership.nature: Held by the Paul Sagan Revocable Trust. Mr. Sagan disclaims beneficial ownership of shares held by the Paul Sagan Revocable Trust except to the extent of his pecuniary interest therein. Read SEC document |
| November 09, 2018 Filed Nov 9, 2018 21:54 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | SaleCommon Stock, par value $.01 per share | 55,500 | $70.46 | $3,910,530.00 |
DisclosureSEC source: 0001086222-18-000212 · wf-form4_154180046356064.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,678 F1 · price: Average sale price per share. Read SEC document |
| August 07, 2018 Filed Aug 8, 2018 20:20 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | Exercise / conversionStock option (right to buy) · Derivative | 39,092 | $38.43 Strike: $38.43 | $1,502,305.56 |
DisclosureSEC source: 0001086222-18-000192 · wf-form4_153375961672592.xml · derivative · entry 3 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 39,092 shares Expires 2019-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option vests as follows: 25% on February 10, 2013, and the remaining 75% vests in equal installments of 6.25% thereafter. Read SEC document |
| August 07, 2018 Filed Aug 8, 2018 20:20 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | SaleCommon Stock, par value $.01 per share | 39,092 | $75.19 | $2,939,327.48 |
DisclosureSEC source: 0001086222-18-000192 · wf-form4_153375961672592.xml · nonDerivative · entry 2 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,178 F1 · kind: Sale was made pursuant to a Rule 10b5-1 Plan. F2 · price: Average sale price per share. Read SEC document |
| August 07, 2018 Filed Aug 8, 2018 20:20 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | Exercise / conversionCommon Stock, par value $.01 per share | 39,092 | $38.43 | $1,502,305.56 |
DisclosureSEC source: 0001086222-18-000192 · wf-form4_153375961672592.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,270 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 20:50 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | Exercise / conversionStock option (right to buy) · Derivative | 39,100 | $38.43 Strike: $38.43 | $1,502,613.00 |
DisclosureSEC source: 0001086222-18-000177 · wf-form4_153263820418169.xml · derivative · entry 3 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,092 Underlying: Common Stock · 39,100 shares Expires 2019-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option vests as follows: 25% on February 10, 2013, and the remaining 75% vests in equal installments of 6.25% thereafter. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 20:50 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | SaleCommon Stock, par value $.01 per share | 39,100 | $79.51 | $3,108,841.00 |
DisclosureSEC source: 0001086222-18-000177 · wf-form4_153263820418169.xml · nonDerivative · entry 2 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,178 F1 · kind: Sale was made pursuant to a Rule 10b5-1 Plan. F2 · price: Average sale price per share. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 20:50 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | Exercise / conversionCommon Stock, par value $.01 per share | 39,100 | $38.43 | $1,502,613.00 |
DisclosureSEC source: 0001086222-18-000177 · wf-form4_153263820418169.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2018 Filed Jul 23, 2018 23:01 UTC | VMWARE LLC VMW · Entity 11690 | GrantClass A Common Stock | 1,824 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-043649 · doc4.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,796 Read SEC document |
| July 10, 2018 Filed Jul 12, 2018 20:50 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | Exercise / conversionStock option (right to buy) · Derivative | 39,100 | $38.43 Strike: $38.43 | $1,502,613.00 |
DisclosureSEC source: 0001086222-18-000169 · wf-form4_153142859341769.xml · derivative · entry 3 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,192 Underlying: Common Stock · 39,100 shares Expires 2019-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option vests as follows: 25% on February 10, 2013, and the remaining 75% vests in equal installments of 6.25% thereafter. Read SEC document |
| July 10, 2018 Filed Jul 12, 2018 20:50 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | SaleCommon Stock, par value $.01 per share | 39,100 | $76.09 | $2,975,119.00 |
DisclosureSEC source: 0001086222-18-000169 · wf-form4_153142859341769.xml · nonDerivative · entry 2 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,178 F1 · kind: Sale was made pursuant to a Rule 10b5-1 Plan. F2 · price: Average sale price per share. Read SEC document |
| July 10, 2018 Filed Jul 12, 2018 20:50 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | Exercise / conversionCommon Stock, par value $.01 per share | 39,100 | $38.43 | $1,502,613.00 |
DisclosureSEC source: 0001086222-18-000169 · wf-form4_153142859341769.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2018 Filed Jan 30, 2019 21:12 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | GiftCommon Stock, par value $.01 per share | 53,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001086222-19-000012 · wf-form5_154888274786924.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See note Disclosed balance after: 311,606 F1 · kind: Shares were gifted to the Fidelity Charitable Trust fund. F2 · ownership.direct: Held by the Paul Sagan Revocable Trust. Mr. Sagan disclaims beneficial ownership of shares held by the Paul Sagan Revocable Trust except to the extent of his pecuniary interest therein. F2 · ownership.nature: Held by the Paul Sagan Revocable Trust. Mr. Sagan disclaims beneficial ownership of shares held by the Paul Sagan Revocable Trust except to the extent of his pecuniary interest therein. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 21:18 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | GrantDeferred Stock Units · Derivative | 2,960 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001086222-18-000139 · wf-form4_152814704215881.xml · derivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,960 Underlying: Common Stock · 2,960 shares Expires 2019-06-02 F1 · derivative.exercise_date: Each deferred stock unit ("DSU") represents the right to receive 1 share of common stock upon vesting. DSUs vest in full on the first anniversary of the date of grant. Read SEC document |
| May 17, 2018 Filed May 18, 2018 20:19 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | Exercise / conversionDeferred Stock Units · Derivative | 4,737 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001086222-18-000113 · wf-form4_152667468925080.xml · derivative · entry 2 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,737 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each deferred stock unit ("DSU") represents the right to receive 1 share of common stock upon vesting. DSUs vest in full on the first anniversary of the date of grant. F2 · derivative.expiration_date: Not applicable. Read SEC document |
| May 17, 2018 Filed May 18, 2018 20:19 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | Exercise / conversionCommon Stock, par value $.01 per share | 4,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001086222-18-000113 · wf-form4_152667468925080.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2017 Filed Aug 7, 2017 21:32 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | Exercise / conversionStock option (right to buy) · Derivative | 53,667 | $41.43 Strike: $41.43 | $2,223,423.81 |
DisclosureSEC source: 0001086222-17-000212 · wf-form4_150214152590515.xml · derivative · entry 4 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,667 shares Expires 2018-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option vests over four years as follows: 25% on February 11, 2012, and the remaining 75% vests in equal installments of 6.25% each quarter thereafter. Read SEC document |
| August 03, 2017 Filed Aug 7, 2017 21:32 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | Exercise / conversionCommon Stock, par value $.01 per share | 53,667 | $41.43 | $2,223,423.81 |
DisclosureSEC source: 0001086222-17-000212 · wf-form4_150214152590515.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2017 Filed Jun 29, 2017 23:32 UTC | VMWARE LLC VMW · Entity 11690 | GiftDell Technologies Class V common stock · Derivative | 9,866 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-042395 · doc4.xml · derivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: see footnote (1) · 9,866 shares Expires not disclosed F1 · derivative.exercise_price: Dell Technologies Inc. ("DT") Class V common stock is intended to track and reflect the economic performance of the Class V Group of DT, which has attributed to it the economic value of a portion of DT's controlling interest in VMware. Accordingly, the Class V stock may be considered a derivative security relating to VMware Class A common stock or an equity security relating to VMware. The filing of this Form 4 shall not be deemed an admission that the Class V stock is a derivative security relating to VMware Class A common stock or an equity security relating to VMware for purposes of Section 16 of the Securities Exchange Act of 1934. F1 · price: Dell Technologies Inc. ("DT") Class V common stock is intended to track and reflect the economic performance of the Class V Group of DT, which has attributed to it the economic value of a portion of DT's controlling interest in VMware. Accordingly, the Class V stock may be considered a derivative security relating to VMware Class A common stock or an equity security relating to VMware. The filing of this Form 4 shall not be deemed an admission that the Class V stock is a derivative security relating to VMware Class A common stock or an equity security relating to VMware for purposes of Section 16 of the Securities Exchange Act of 1934. F1 · derivative.exercise_date: Dell Technologies Inc. ("DT") Class V common stock is intended to track and reflect the economic performance of the Class V Group of DT, which has attributed to it the economic value of a portion of DT's controlling interest in VMware. Accordingly, the Class V stock may be considered a derivative security relating to VMware Class A common stock or an equity security relating to VMware. The filing of this Form 4 shall not be deemed an admission that the Class V stock is a derivative security relating to VMware Class A common stock or an equity security relating to VMware for purposes of Section 16 of the Securities Exchange Act of 1934. F1 · derivative.expiration_date: Dell Technologies Inc. ("DT") Class V common stock is intended to track and reflect the economic performance of the Class V Group of DT, which has attributed to it the economic value of a portion of DT's controlling interest in VMware. Accordingly, the Class V stock may be considered a derivative security relating to VMware Class A common stock or an equity security relating to VMware. The filing of this Form 4 shall not be deemed an admission that the Class V stock is a derivative security relating to VMware Class A common stock or an equity security relating to VMware for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:11 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | Exercise / conversionStock option (right to buy) · Derivative | 17,889 | $41.33 Strike: $41.43 | $739,352.37 |
DisclosureSEC source: 0001086222-17-000197 · wf-form4_149764387482160.xml · derivative · entry 4 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,667 Underlying: Common Stock · 17,889 shares Expires 2018-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option vests over four years as follows: 25% on February 11, 2012, and the remaining 75% vests in equal installments of 6.25% each quarter thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.